Although this gene-editing technology promises impressive improvements in healthcare, various obstacles must be addressed before large numbers of patients can benefit.
Based on a growing body of data, some experts believe that pharmacogenomics-guided spaceflight is the foundation of precision medicine, a feature that they believe will enable long-term human habitation on the Moon.
In the U.S., pain annually affects 100 million Americans, amounting to half a trillion dollars in terms of economic burden. Still, the opioid epidemic rages on, a major cause for mortality among young adults.
The team identified a panel of 27 proteins as biomarkers of cardiomyopathy risk when measured in blood serum.
The findings support the use of the PARP inhibitor as adjuvant therapy after standard treatments like chemotherapy, surgery, and radiation.
Scientists have taken a step toward patient-specific radiation therapies by repurposing the KRAS G12C inhibitor sotorasib to make it a target for radioactive antibodies when bound to tumor cells.
Scientists have programmed CAR T cells to home in on brain-specific markers like brevican, enabling highly targeted treatment for glioblastoma and other brain conditions.
Despite being the leading cause of fetal and maternal morbidity worldwide, there is still no treatment for pre-eclampsia. Now, an mRNA treatment for pre-eclampsia that works by restoring abnormal placental blood vessels improved maternal and fetal health in mice.
Researchers at the Cleveland Clinic have discovered definitive proof that the kidney microbiome influences the formation of kidney stones—showing that the urinary tract is not sterile and low levels of bacteria are normal.
Relation will receive a total upfront payment from GSK of $45 million—including an equity investment of $15 million.
